Anzalone Christopher Richard sold ARWR
March 3, 2025 · Form 4 insider transaction
Anzalone Christopher Richard sold 133,333 shares of Arrowhead Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
133,333
Price
$0.00
Total value
N/A
InsiderAnzalone Christopher Richard
Role—
SecurityStock Option (right to buy Common Stock)
Transaction codeM: Option exercise
Transaction dateMarch 3, 2025
Filing dateMarch 5, 2025
Shares owned after51,726
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
All options were fully vested and exercisable as of March 6, 2015.